NEOGEN2026-04-012026-06-30NEOGEN2026-06-30NEOGEN2026-04-012026-06-30in-capmkt:OtherExpenses1MemberNEOGEN2026-04-012026-06-30ItemsThatWillNotBeReclassifiedToProfitAndLoss1NEOGEN2026-04-012026-06-30AuditorDomain1NEOGEN2026-06-30Statement1NEOGEN2026-04-012026-06-30Statement1NEOGEN2026-06-30StatementDynamic1I1Statement1NEOGEN2026-06-30StatementDynamic1I2Statement1NEOGEN2026-06-30StatementDynamic1I3Statement1iso4217:INRxbrli:pureiso4217:INRxbrli:shares542665NEOGENNOTLISTEDINE136S01016NEOGEN CHEMICALS LIMITEDMain BoardEquity2026-04-012027-03-312026-07-242026-07-20INRCroresQuarterlyFirst quarterSingle segmentSpecialty Chemicals2026-07-2414:00:002026-07-2418:30:00Declaration of unmodified opiniontrue1falseNA2026-04-012026-06-30UnauditedStandalone2522800000790000002601800000176530000074900000-407800000214000000231000000683000003948000002340500000261300000026130000060300000660000066900000019440000000001944000001400000195800000273800000107.157.15007.157.15The above unaudited standalone financial results of the Company for the quarter ended June 30, 2026 have <br /> been prepared in accordance with the IND AS, as prescribed under section 133 of the Companies Act, 2013 <br /> read with the Companies (Indian Accounting Standards) Rules, 2015 as amended and the other accounting <br /> principles generally accepted in India and are in compliance with the disclosure requirement of Regulations 33 <br /> and Regulations 52 of the Securities and Exchange Board of India (Listing Obligations & Disclosure <br /> Requirements) Regulations, 2015 as amended and were reviewed by the Statutory Auditor and recommended <br /> by the Audit Committee in its meeting held on July 24, 2026, to the Board for approval and was approved by <br /> the Board of Directors at their meeting held on July 24, 2026. <br /> 3. On March 05, 2025, there was fire at Multi-Purpose Plant (MPP3) Facility, Tank Farms and warehouse at Dahej <br /> SEZ Plant of the Company. This incident led to damage of certain property, plant and equipment, inventory and <br /> interrupted business. The Company is adequately insured for reinstatement value of damaged fixed assets, <br /> inventory and loss of profits due to business interruption. The Company has intimated the fire incident with <br /> the insurance company and submitted loss estimate pertaining to replacement value of the damaged property, <br /> plant and equipment, loss of damaged inventory and incidental expenses incurred on account of fire. The Claim <br /> is admitted by the insurance company. <br /> During the financial year ended March 31, 2025, the Company has recognised loss of Rs. 348.16 Crore on account <br /> of damage to certain property, plant & equipment, inventory and estimated cost of incidental charges. The <br /> Company has recognised insurance claim receivable of Rs. 334.60 Crore to the extent of recovery of loss after <br /> adjusting applicable deductibility considering its assessment of loss and admissibility of claims as per the policy, <br /> adequacy of coverage and nature of loss and based upon the independent opinion obtained by the company <br /> from Independent Surveyor and Independent Expert Practitioner. The Company has not accounted claim for <br /> loss of profit due to business interruption and excess value of reinstatement of assets over written down value <br /> as per accounting conservatism. The aforementioned losses and corresponding insurance claim has been presented on a net basis of Rs. 13.56 Crore under exceptional item and claim receivable in other current financial <br /> assets in these standalone financial results for the financial year ended March 31, 2025. <br /> The Company has received Rs. 149.38 Crore (Rs.140.00 Crore as on account payment from insurance company and <br /> balance Rs. 9.38 Crore pertains to sale of scrap) and incurred further incidental charges of Rs. 1.41 Crore which is <br /> also claimed as per insurance policy upto June 30, 2026. <br /> Subsequent to the quarter ended 30 June 2026, the Company has received additional Rs. 15.00 Crore as fourth <br /> on account payment from Insurance company, accordingly net claim receivable as on date reduced to Rs. 171.63 <br /> Crore.The Board of Directors of the Company, at its meeting held on March 7, 2026, inter alia approved the issue and <br /> offer of 10,00,000 equity shares of face value of Rs. 10 each at a price of Rs. 1,610 per Equity Share including a <br /> premium of Rs. 1,600 per Equity Share, aggregating to Rs. 1,61,00,00,000 (Rupees One Hundred and Sixty One <br /> Crore only) on preferential basis for cash consideration. Subsequently, the shareholders of the Company at its <br /> Extra Ordinary General meeting (EGM) held on March 29, 2026, has approved issue, offer and allotment of the <br /> said 10,00,000 equity shares to Cadamba Solutions Private Limited, a Promoter Group member of the <br /> Company. The allotment of the said equity shares of the Company on a preferential basis was done on April <br /> 18, 2026. The Equity Shares were listed on BSE Limited and National Stock Exchange of India Limited. <br /> Further we hereby confirm that there have been no deviations in the use of proceeds of issue of equity shares <br /> on preferential basis from the objects stated in the Notice dated March 7, 2026 for EGM held on March 29,2026 <br /> read with corrigendum to the said notice of EGM dated March 17, 2026 , for the quarter ended June 30,2026 <br /> and the intimation in this regard is being made available at https://neogenchem.com/announcements/ under <br /> the tab issue of securities and at the website of BSE Limited at https://www.bseindia.com/stock-shareprice/ <br /> neogen-chemicals-ltd/neogen/542665 and of National Stock exchange of India Limited at <br /> https://www.nseindia.com/get-quote/equity/NEOGEN/Neogen-Chemicals-Limited .During the quarter ended June 30, 2026, the Company has subscribed to Unsecured Compulsorily Convertible <br /> Debentures ("CCDs") amounting to Rs. 114.00 Crore of Neogen Ionics Limited (“wholly owned subsidiary”). The <br /> Company had also paid the share application money against CCD of Rs. 6 Crore to wholly owned subsidiary, the <br /> allotment against which was completed in July 2026.# The figures for the quarter ended March 31, 2026 is arrived at as difference between the audited figures in <br /> respect of the full financial year and the unaudited figures up to nine months period ended December 31, 2025 <br /> which were subjected to limited review. <br /> Previous period / year's figures have been regrouped / rearranged wherever necessary to make them <br /> comparable with the current period's classification. <br /> The Company deals in Specialty Chemicals and considering that the nature of products and the predominant <br /> risk and returns of the products are similar, the Company considers it as one operating segment in accordance <br /> with Ind AS 108.The above unaudited standalone financial results under SEBI (Listing Obligations and Disclosure Requirements) <br /> Regulations, 2015 for the quarter ended June 30, 2026 are available at the Company's website at <br /> https://necgenchem.com/financial-performance/, https://neogenchem.com/annual-reports-2/ and Stock <br /> Exchange's website at www.nseindia.com and www.bseindia.com.Other Expenses394800000Amount of items that will not be reclassified to profit and loss1900000190000050000001400000UnauditedfalseM/s. Chandabhoy & Jassoobhoy, Chartered Accountantstrue2026-10-31OthersPreferential Issue of Equity Shares2026-04-1816100000002026-06-30trueCRISIL Ratings LimitedfalseGopikrishnan SarathyChief Financial OfficerThane2026-07-24Investment in wholly owned subsidiaries of the Company viz. Neogen Ionics LimitedNo1000000000010000000000Meeting Working capital requirementsNo21000000002100000000General Corporate Purposes*No40000000004000000000*The amount utilized for general corporate purpose does not exceed 25% of the Gross Proceeds.